Provided by Tiger Trade Technology Pte. Ltd.

Agilent

168.17
-0.9200-0.54%
Post-market: 168.170.00000.00%16:04 EDT
Volume:2.71M
Turnover:450.21M
Market Cap:47.60B
PE:33.16
High:168.66
Open:167.48
Low:163.32
Close:169.09
52wk High:177.05
52wk Low:108.35
Shares:283.05M
Float Shares:281.64M
Volume Ratio:1.20
T/O Rate:0.96%
Dividend:1.01
Dividend Rate:0.60%
EPS(TTM):5.07
EPS(LYR):4.59
ROE:20.97%
ROA:8.63%
PB:6.46
PE(LYR):36.65

Loading ...

Qingdao Establishes Top-Tier Framework to Foster High Growth of Tech Enterprises

Deep News
·
Jul 31

SunCar Technology Group Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Compliance Deficiency

GlobeNewswire
·
Jul 31

Phathom Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update

GlobeNewswire
·
Jul 30

Silicon Motion Announces Results for the Quarterly Period Ended June 30, 2026

GlobeNewswire
·
Jul 30

CTS Announces Second Quarter 2026 Results

GlobeNewswire
·
Jul 28

Revvity Inc. Stock Underperforms Monday When Compared to Competitors

Dow Jones
·
Jul 28

Revvity Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Jul 25

Billionaire Investor Dumps Thermo Fisher, Cuts Danaher As He Pares Life Sciences Tools Bets

Benzinga Earnings
·
Jul 25

FangDD Received Nasdaq Notification Regarding Minimum Bid Price Requirement

GlobeNewswire
·
Jul 24

Agilent Technologies Inc. Stock Underperforms Thursday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Jul 24

Agilent Declares Q2 2026 Distribution of R$ 0.44 Per Unit, Payable July 28

Reuters
·
Jul 24

Real Messenger Announces Receipt of Nasdaq Notification Letter Regarding Minimum Price Deficiency

GlobeNewswire
·
Jul 23

Agilent Receives EU Certification for Keytruda Companion Diagnostic in Gynecologic Cancers

MT Newswires Live
·
Jul 23

Agilent receives EU approval for PD-L1 IHC 22C3 pharmDx

TIPRANKS
·
Jul 23

Agilent Wins EU Approval for PD-L1 IHC 22C3 Test in Ovarian Cancer Patients

Reuters
·
Jul 23

Agilent Receives EU Approval for Pd-l1 Ihc 22C3 Pharmdx in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma

THOMSON REUTERS
·
Jul 23

Agilent Technologies - Approval Expands Pd-l1 Testing to Support Keytruda Treatment Decisions

THOMSON REUTERS
·
Jul 23

Bernstein Sticks to Its Buy Rating for Agilent (A)

TIPRANKS
·
Jul 23

Agilent BDR Program Executes 5-for-1 Stock Split on Ratio Adjustment

Reuters
·
Jul 22

Agilent Technologies (A) Wins FDA Approval, Where Does Fair Value Sit Now?

Simply Wall St.
·
Jul 21